Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | NAAA | Q02083 | 5/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10617495 | 1.00 | ALDH1A1 (0.33) | ALDH1A1PKMHPGDKCNH2NAAA | |
| SCHEMBL8721243 | 0.92 | EPHX2 (0.38) | ALDH1A1 | |
| SCHEMBL20954129 | 0.87 | SCN2A (0.36) | ALDH1A1 | |
| SCHEMBL20954138 | 0.87 | SCN2A (0.36) | ALDH1A1 | |
| SCHEMBL11138004 | 0.87 | SCN2A (0.36) | ALDH1A1 | |
| SCHEMBL4665788 | 0.87 | SCN2A (0.36) | ALDH1A1 | |
| SCHEMBL7698170 | 0.85 | NOS1 (0.36) | — | |
| SCHEMBL324903 | 0.83 | GBA1 (0.35) | ALDH1A1NAAAGAA | |
| SCHEMBL1648426 | 0.83 | GBA1 (0.35) | ALDH1A1NAAAGAA | |
| SCHEMBL7778401 | 0.83 | HTR2A (0.36) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0296199-A1 | HETEROCYCLIC COMPOUNDS FOR TRANSDERMAL USE | RAJADHYAKSHA, Vithal J. (US) | 1988-12-28 | — | — | EP | claimed |
| WO-1988004938-A1 | HETEROCYCLIC COMPOUNDS FOR TRANSDERMAL USE | RAJADHYAKSHA VITHAL J (US) | 1988-07-14 | — | — | WO | claimed |
| EP-4569023-A1 | COMBINATION OF CATALYTIC COMPONENTS | PolyU GmbH (DE) | 2025-06-18 | — | — | EP | disclosed |
| WO-2024033348-A1 | COMBINATION OF CATALYTIC COMPONENTS | POLYU GMBH (DE) | 2024-02-15 | — | — | WO | disclosed |
| EP-4321573-A1 | COMBINATION OF CATALYTIC COMPONENTS | PolyU GmbH (DE) | 2024-02-14 | — | — | EP | disclosed |
| EP-2388297-B1 | CURABLE COMPOSITION AND CURED OBJECT FORMED THEREFROM | KANEKA CORP (JP) | 2020-08-19 | — | — | EP | disclosed |
| CN-106574114-B | Curable organopolysiloxane composition | 瓦克化学股份公司 | 2019-10-15 | — | — | CN | disclosed |
| US-10301433-B2 | Curable organopolysiloxane compositions | WACKER CHEMIE AG (DE) | 2019-05-28 | — | — | US | disclosed |
| EP-3172178-B1 | CURABLE ORGANOPOLYSILOXANE COMPOSITIONS | WACKER CHEMIE AG (DE) | 2018-09-12 | — | — | EP | disclosed |
| US-20170210856-A1 | CURABLE ORGANOPOLYSILOXANE COMPOSITIONS | WACKER CHEMIE AG (DE) | 2017-07-27 | — | — | US | disclosed |
| EP-1939257-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2017-06-21 | — | — | EP | disclosed |
| CN-106574114-A | Curable organopolysiloxane compositions | 瓦克化学股份公司 | 2017-04-19 | — | — | CN | disclosed |
| EP-2388297-A1 | CURABLE COMPOSITION AND CURED OBJECT FORMED THEREFROM | Kaneka Corporation (JP) | 2011-11-23 | — | — | EP | disclosed |
| US-8013079-B2 | Curable composition | KANEKA CORPORATION (JP) | 2011-09-06 | — | — | US | disclosed |
| US-20100036049-A1 | CURABLE COMPOSITION | KANEKA CORPORATION | 2010-02-11 | — | — | US | disclosed |
| EP-1939257-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2008-07-02 | — | — | EP | disclosed |